Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807).

Otterson GA, Herndon JE, Watson D, Green MR, Kindler HL. Capecitabine in malignant mesothelioma: a phase II trial by the Cancer and Leukemia Group B (39807). Lung Cancer. 2004 May; 44(2):251-9.

View in: PubMed

collapse authors with profiles